(Date:12/15/2009)... LONDON, Dec. 15 Thomson ... Pharma ® has become the first drug pipeline ... and outcome information. This highly anticipated new content ... this month. ,, Thomson Pharma ... from registries, publications, press releases, conferences, and other ...
(Date:12/14/2009)... International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced today ... Scripps Research Institute ("Scripps") by entering into an ... Dyadic,s patented and proprietary C1 fungus ("C1"). ,, ... relationship between the two organizations which began in ... the C1 genome for the first time. The ...
(Date:12/14/2009)... Dec. 14 Nektar Therapeutics (Nasdaq: ... been appointed to serve on its board of ... leader with over 35 years of experience in ... brings to Nektar extensive industry perspective at an ... W. Robin, President and CEO of Nektar and ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3... Neurosciences, Inc. Launches a Self-Guided Lesson as Prep for ... ... 13 In recognition that physician,comfort and knowledge with techniques ... with cervical dystonia (CD), Solstice,Neurosciences, Inc. (Solstice) has created MYOBLOC(TM) ...
... December 13 Synosia Therapeutics today,announced the appointment ... business officer, effective immediately., Dr Blanc, who ... Basel,Switzerland, joins from Syngenta, where he created and ... training and an,experienced biotech entrepreneur, Dr. Blanc helped ...
... SAN DIEGO, Dec. 13 Neurocrine Biosciences,Inc. (Nasdaq: ... from the U.S. Food and Drug Administration (FDA) indicating,that ... and 10 mg capsules,for the treatment of insomnia is ... 15, 2006, the Company received an action letter from ...
Other Biology Technology:New Online Learning Tool Fills the Knowledge Gap on Botulinum Toxin Type B for Cervical Dystonia 2New Online Learning Tool Fills the Knowledge Gap on Botulinum Toxin Type B for Cervical Dystonia 3Synosia Therapeutics Announces Appointment of Chief Business Officer 2Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA 2Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA 3Unit Definition: 1 U corresponds to the amount of enzyme which produces 1 mol protons per minute at pH 5.5 and 30C (peptin from citrus peel, Fluka-No. 76280, as substrate)...
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed...
... systems provide linking and labelling reagents ... specific primary antibodies for visualising cellular ... accomplished using an ultra-sensitive indirect labelling ... technology. Secondary antibodies are polymerised directly ...
Taq DNA Polymerase (T. aquaticus), 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzyme...
Biology Products:Pectinase from Sigma-AldrichRecorder, 6", 7 Day, 1 Pen, 0 to 100C, Free Standing, 115V, 50/60 Hz, for 4520, Customer Installed from Thermo ScientificHISTAR DETECTION KIT from AbD SerotecTaq DNA Polymerase (Thermus aquaticus) from GE Healthcare, formerly Amersham Biosciences Biology NavigationMedical Navigation